Search Our Website:

​Mike Strazzella, head of the firm's Federal Government Relations practice group, considers the impact of the Trump administration's recent rule in an effort to increase drug pricing transparency in Modern Healthcare's article "Hospitals Sue HHS Over Negotiated Price Disclosure Rule."

"Yes, a solution has been put forward, but is it the right solution? Is it a workable solution?" said Mike Strazzella, head of federal government relations at Buchanan, Ingersoll and Rooney.